Prime Medicine

Prime Medicine is a clinical-stage biotechnology company developing a new class of differentiated one-time curative genetic therapies built on Prime Editing, a versatile, precise, and efficient gene editing technology that can search and replace disease-causing genetic sequences at their precise location in the genome without causing double-strand DNA breaks. The company is advancing a pipeline of programs across a broad range of diseases and, per its public materials, believes Prime Editing could theoretically correct approximately 90% of known disease-causing genetic mutations. It is publicly traded and surfaced in the API Evangelist network as a portfolio company of GV (Google Ventures). This is a corporate/life-sciences profile: the company publishes no public developer API, developer portal, or API documentation.

Prime Medicine is profiled on the APIs.io network. Tagged areas include Company, Life Sciences, Biotechnology, Gene Editing, and Prime Editing.

🌐 Visit website 📡 Source on GitHub

9.0/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-08-20 · rubric v0.12.0

0 APIs

Company Life Sciences Biotechnology Gene EditingPrime EditingGenetic Medicine Therapeutics

Kin Score

Kin Score How this is scored →
scored 2026-08-20 · rubric v0.12.0

Composite quality — 9.0/100 · minimal

Contract Quality 0.0 / 21

Developer Ergonomics 0.0 / 17

Access Clarity 3.6 / 17

Operational Transparency 0.0 / 11

Contract Governance 0.0 / 10

Discoverability 4.3 / 9

Regulatory Posture 2.6 / 15

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 10

Documented Reversibility 0 / 6

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

A2A Agent Card 0 / 8

Dry-Run / Simulate Mode 0 / 4

Regulatory Posture applies to this provider. Its tags matched the Health regime, so Regulatory Posture carries 15 points of the composite. If this regime is wrong for your business, say so on your provider repo — the applicability map is public and we will correct it.

The six quality facets above are damped to 85 points between them, because the conditional facet above carries the other 15. That is why each facet's contribution is shown against a damped maximum: raising a quality facet moves the composite by 85% of its nominal weight, not 100%. The full arithmetic is at apis.io/rating/.

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/prime-medicine: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Commercial 2

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

TermsOfService

TermsOfService

Company 4

The organization behind the API

Website

About

Careers

Investors

Other 2

Properties that don't map to a standard resource type

Science

Science

Pipeline

Pipeline

Source (apis.yml)

aid: prime-medicine
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/prime-medicine.png
name: Prime Medicine
description: 'Prime Medicine is a clinical-stage biotechnology company developing a new class of differentiated one-time curative
  genetic therapies built on Prime Editing, a versatile, precise, and efficient gene editing technology that can search and
  replace disease-causing genetic sequences at their precise location in the genome without causing double-strand DNA breaks.
  The company is advancing a pipeline of programs across a broad range of diseases and, per its public materials, believes
  Prime Editing could theoretically correct approximately 90% of known disease-causing genetic mutations. It is publicly traded
  and surfaced in the API Evangelist network as a portfolio company of GV (Google Ventures). This is a corporate/life-sciences
  profile: the company publishes no public developer API, developer portal, or API documentation.'
url: https://raw.githubusercontent.com/api-evangelist/prime-medicine/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.23'
created: '2026-07-17'
modified: '2026-07-20'
tags:
- Company
- Life Sciences
- Biotechnology
- Gene Editing
- Prime Editing
- Genetic Medicine
- Therapeutics
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: Website
  url: https://primemedicine.com
- type: About
  url: https://primemedicine.com/about/
- type: Science
  url: https://primemedicine.com/science/
- type: Pipeline
  url: https://primemedicine.com/pipeline/
- type: Careers
  url: https://primemedicine.com/careers/
- type: Investors
  url: https://investors.primemedicine.com
- type: PrivacyPolicy
  url: https://primemedicine.com/privacy-policy
- type: TermsOfService
  url: https://primemedicine.com/terms-of-use
- type: DomainSecurity
  url: security/prime-medicine-domain-security.yml
x-enrichment:
  date: '2026-07-20'
  status: minimal
  artifacts_added: 1
  pass: local-v1